Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 9 (RPL21P9) is a pseudogene in the human genome; it is related to the functional ribosomal protein L21 gene (RPL21), but does not code for a functional protein and is generally considered non-coding. Pseudogenes like RPL21P9 arise as genomic copies of protein-coding genes that have lost their ability to encode functional proteins, often due to disabling mutations or lack of regulatory elements. They have no known direct biological or disease roles, are not therapeutic targets, and are not associated with drug interactions or mechanisms of action[1][2][6]. Key context: - The canonical, protein-coding form is ribosomal protein L21 (RPL21), a component of the 60S ribosomal subunit essential for protein synthesis[5][7]. - RPL21P9 is one of several processed pseudogenes for RPL21 that are dispersed throughout the genome and do not have known functional activity[1][6]. If you require information about the functional ribosomal protein (RPL21), and not the pseudogene, clarify and the corresponding structured data can be provided.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 9 (RPL21P9).